| Literature DB >> 26088065 |
Andrea Cerciello1, Giulia Auriemma1, Silvana Morello1, Aldo Pinto1, Pasquale Del Gaudio1, Paola Russo1, Rita P Aquino1.
Abstract
For the treatment of inflammatory-based diseases affected by circadian rhythms, the development of once-daily dosage forms is required to target early morning symptoms. In this study, Zn-alginate beads containing ketoprofen (K) were developed by a tandem technique prilling/ionotropic gelation. The effect of main critical variables on particles micromeritics, inner structure as well as on drug loading and in vitro drug release was studied. The in vivo anti-inflammatory efficacy was evaluated using a modified protocol of carrageenan-induced edema in rat paw administering beads to rats by oral gavage at 0, 3, or 5 h before edema induction. Good drug loading and desired particle size and morphology were obtained for the optimized formulation F20. In vitro dissolution studies showed that F20 had a gastroresistant behavior and delayed release of the drug in simulated intestinal fluid. The in vitro delayed release pattern was clearly reflected in the prolonged anti-inflammatory effect in vivo of F20, compared to pure ketoprofen; F20, administered 3 h before edema induction, showed a significant anti-inflammatory activity, reducing maximum paw volume in response to carrageenan injection, whereas no response was observed for ketoprofen. The designed beads appear a promising platform suitable for a delayed release of anti-inflammatory drugs.Entities:
Keywords: alginate; dissolution; microencapsulation; microparticles; oral drug delivery; polymeric drug delivery systems; solid dosage form
Mesh:
Substances:
Year: 2015 PMID: 26088065 DOI: 10.1002/jps.24554
Source DB: PubMed Journal: J Pharm Sci ISSN: 0022-3549 Impact factor: 3.534